ST3GAL5 and Alzheimer disease: Similar protection from AD pathology was achieved by knocking out St3gal5 (GM3 synthase) in the 5XFAD mouse model of AD, which resulted in the lack of both a- and b-series gangliosides (Dukhinova et al., 2019).